Initial Results Expected News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Initial Results Expected. Real-time updates on events, politics, business and more.

Viking Therapeutics Reports Second Quarter 2022 Financial Results and Provides Corporate Update

July 27, 2022

/PRNewswire/ -- Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies...

New York United States Prnewswire Viking Therapeutics Inc Morgan Stanley Ligand Pharmaceuticals Incorporated Drug Administration

Source: prnewswire.com

Viking Therapeutics Reports Second Quarter 2022 Financial Results and Provides Corporate Update

July 27, 2022

/PRNewswire/ -- Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies...

New York United States Prnewswire Viking Therapeutics Inc Morgan Stanley Ligand Pharmaceuticals Incorporated Drug Administration

Source: prnewswire.com

Rubius Therapeutics Reports First Quarter 2022 Financial Results and Provides Business Update

May 10, 2022

Presented Updated Clinical Data from Monotherapy Phase 1 Arm of RTX-240 Clinical Trial in Advanced Solid Tumors, Showing Clinical Responses with Favorable Tolerability in PD-1 Refractory Disease ... | May 10, 2022

Rhode Island United States United Kingdom Marissa Hanify Lori Murray Pabloj Cagnoni

Source: marketscreener.com

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science

Navigation

Initial Results Expected News Today

Viking Therapeutics Reports Second Quarter 2022 Financial Results and Provides Corporate Update

Viking Therapeutics Reports Second Quarter 2022 Financial Results and Provides Corporate Update

Rubius Therapeutics Reports First Quarter 2022 Financial Results and Provides Business Update

Explore More Categories